Mechanism for the Selective Uptake of Macular Carotenoids Mediated by the HDL Cholesterol Receptor SR-BI
Overview
Authors
Affiliations
The macular carotenoids lutein and zeaxanthin are taken up from the bloodstream into the human retina through a selective process, for which the HDL cholesterol receptor scavenger receptor BI (SR-BI) in the cells of retinal pigment epithelium (RPE) is thought to be a key mediator. However, the mechanism of SR-BI-mediated selective uptake of macular carotenoids is still not fully understood. Here, we investigate possible mechanisms using biological assays and cultured HEK293 cells, a cell line without endogenous SR-BI expression. Binding affinities between SR-BI and various carotenoids were measured by surface plasmon resonance (SPR) spectroscopy, which shows that SR-BI cannot bind lutein or zeaxanthin specifically. Overexpression of SR-BI in HEK293 cells results in more lutein and zeaxanthin taken up than β-carotene, and this effect can be eliminated by an SR-BI mutant (C384Y) whose cholesterol uptake tunnel is blocked. Next, we determined the effects of HDL and hepatic lipase (LIPC), SR-BI's partners in HDL cholesterol transport, on SR-BI-mediated carotenoid uptake. HDL addition dramatically reduced lutein, zeaxanthin, and β-carotene in HEK293 cells expressing SR-BI, but the cellular lutein and zeaxanthin are higher than β-carotene. LIPC addition increases the uptake of all three carotenoids in HDL-treated cells, and promotes the transport of lutein and zeaxanthin better than β-carotene. Our results suggest that SR-BI and its HDL cholesterol partner HDL and LIPC may be involved in the selective uptake of macular carotenoids.
Bijon J, Hussain M, Bredefeld C, Boesze-Battaglia K, Freund K, Curcio C Ophthalmic Genet. 2024; 45(6):583-590.
PMID: 39373891 PMC: 11598668. DOI: 10.1080/13816810.2024.2411290.
Li B, Chang F, Wan Z, Giauque N, Addo E, Bernstein P Exp Eye Res. 2024; 247:110043.
PMID: 39151780 PMC: 11412777. DOI: 10.1016/j.exer.2024.110043.
Rozanowska M, Edge R, Land E, Navaratnam S, Sarna T, Truscott T Int J Mol Sci. 2024; 25(1).
PMID: 38203675 PMC: 10779001. DOI: 10.3390/ijms25010506.
Lieffrig S, Gyimesi G, Mao Y, Finnemann S Immunol Rev. 2023; 319(1):81-99.
PMID: 37555340 PMC: 10615845. DOI: 10.1111/imr.13264.
Grudzinski W, Luchowski R, Ostrowski J, Sek A, Mendes Pinto M, Welc-Stanowska R Int J Mol Sci. 2023; 24(13).
PMID: 37445880 PMC: 10342121. DOI: 10.3390/ijms241310702.